Industry Newshealthcare technologyhealth insuranceoscar healthanalyst ratings
Raymond James Upgrades Oscar Health Stock
|
5.1
Raymond James upgraded Oscar Health to Outperform on Feb. 12 with an $18 price target, saying valuation looks appealing as ACA exchange margins recover. The firm forecasts EBIT margins near 2% in 2026 rising to about 4% in 2027, driven by lower medical costs and administrative efficiency. UBS lowered its price target to $15 on Feb. 11 while retaining Neutral.
Scoring Rationale
Moderate actionable analyst upgrade and margin forecasts; limited novelty and sector-specific relevance reduce broader impact.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
Used by DS/ML engineers at top companies
250 free problems · No credit card
See all Health & Insurance problems
